Helus Pharma reported cash from operations of -$37.07M and free cash flow of -$36.75M for the quarter ended Jun 2026, down 25.5% year over year. This cash flow statement covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow StatementCash Flow | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||||
| Net Income | -13.99M | -13.65M | -14.29M | -10.24M | -7.65M | -7.91M | -10.15M | -10.80M | -8.87M | -22.28M | -15.84M | -10.84M | -41.92M | -7.55M | -21.31M | -24.61M | -33.72M | -42.67M | -47.00M | -47.82M | |||||
| Depreciation and DepletionDep. & Depletion | 0.03M | 0.03M | 0.03M | 0.04M | |||||||||||||||||||||
| Depreciation, Depletion & Amortization | |||||||||||||||||||||||||
| Amortization of Deferred ChargesAmort. Deferred Charges | |||||||||||||||||||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 0.03M | 0.03M | 0.03M | 0.04M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.10M | 0.11M | 0.10M | 0.10M | 0.09M | 0.04M | 0.04M | 0.03M | 0.02M | 0.03M | 0.03M | |||||
| Share-based CompensationStock Comp. | 4.34M | 3.54M | 2.64M | 1.69M | 0.82M | 0.72M | 0.36M | 0.95M | 1.05M | 7.29M | 0.94M | 2.90M | 24.53M | 2.39M | 1.46M | 0.75M | 0.38M | 4.48M | 5.26M | 11.57M | |||||
| Gains from Investment SecuritiesGains Investment | 0.36M | -11.00M | |||||||||||||||||||||||
| Asset Writedowns and ImpairmentWritedown | -0.01M | ||||||||||||||||||||||||
| Other non-cash itemsOther Non-Cash | 0.51M | 0.55M | -0.02M | 0.24M | 0.02M | -0.26M | 0.00M | 0.00M | 0.00M | 0.02M | -1.94M | 0.76M | 0.02M | ||||||||||||
| Change in Working Capital | |||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | -0.48M | 0.09M | 1.27M | -0.13M | -0.44M | 0.18M | 1.07M | -0.12M | -0.35M | -0.17M | 1.45M | -0.10M | -0.65M | -0.06M | 1.75M | -0.01M | -0.63M | -0.03M | 1.61M | -0.01M | |||||
| Change in InventoryChange Inventory | |||||||||||||||||||||||||
| Change in Accrued ExpensesChange Accrued Exp. | -0.34M | 0.33M | 1.75M | 0.53M | -0.81M | -0.38M | 0.96M | 0.25M | 2.42M | -5.72M | 1.24M | -3.80M | 1.93M | 4.34M | 5.65M | -0.35M | -1.19M | 2.82M | 3.20M | -1.81M | |||||
| Change in Other Operating AssetsOther Assets Change | -0.93M | -0.53M | 2.38M | 0.01M | -1.46M | 0.20M | 1.86M | 0.32M | -1.32M | -0.05M | 2.08M | -5.82M | -4.72M | -4.00M | 27.87M | -3.75M | -5.26M | 2.84M | 10.97M | 0.94M | |||||
| Other Working Capital ChangesOther WC Changes | 0.93M | 0.53M | -2.38M | -0.01M | 1.46M | -0.20M | -1.86M | -0.32M | 1.32M | 0.05M | -2.08M | 5.82M | 4.72M | 4.00M | -27.87M | 3.75M | 5.26M | -2.84M | -10.97M | -0.94M | |||||
| Other Operating Activities (as filed) | 1.00M | 1.42M | |||||||||||||||||||||||
| Cash from OperationsCash from Ops. | -10.96M | -10.17M | -7.67M | -8.74M | -11.26M | -7.94M | -8.02M | -7.96M | -8.55M | -19.13M | -15.37M | -19.89M | -19.11M | -18.59M | -14.71M | -29.55M | -34.49M | -31.95M | -37.29M | -37.07M | |||||
| Investing Activities | |||||||||||||||||||||||||
| Capital ExpendituresCapex | -0.02M | -0.02M | 0.16M | -0.11M | 0.21M | -0.13M | 0.38M | -0.22M | -0.76M | -0.23M | -0.44M | -0.38M | -0.32M | -0.32M | |||||||||||
| Sales of Property, Plant and EquipmentPP&E (Sale) | 0.01M | ||||||||||||||||||||||||
| Change in Property, Plant and EquipmentChange in PP&E | 0.02M | 0.02M | -0.16M | 0.11M | -0.21M | 0.13M | -0.38M | 0.22M | 0.76M | 0.24M | 0.44M | 0.38M | 0.32M | 0.32M | |||||||||||
| Change in IntangiblesChange Intangibless | -0.05M | -0.11M | 0.57M | -0.05M | -2.05M | -0.15M | 4.52M | -0.05M | -0.19M | -0.12M | 0.87M | -0.17M | |||||||||||||
| Purchase of InvestmentsInvestments Purchased | 0.39M | ||||||||||||||||||||||||
| Other Investing Activities (as filed)Other investing (as filed) | |||||||||||||||||||||||||
| Cash from Investing ActivitiesCash from Investing | -0.07M | -0.13M | -0.10M | -0.16M | -2.05M | -0.15M | -0.16M | -0.05M | -0.19M | 5.48M | -0.16M | -0.17M | -0.25M | -0.22M | -0.76M | -0.22M | -0.44M | -0.38M | -0.32M | -0.32M | |||||
| Financing Activities | |||||||||||||||||||||||||
| Debt Issuance and Repayment | |||||||||||||||||||||||||
| Long-Term Debt IssuancesLT Debt Issuance | 44.50M | ||||||||||||||||||||||||
| Long-Term Debt RepaymentsLT Debt Repayment | 40.30M | ||||||||||||||||||||||||
| Net Long-Term Debt Issued (Repaid)Net LT Debt | 44.50M | -40.30M | |||||||||||||||||||||||
| Net Debt Issuances and RepaymentsNet Debt Issuance | 44.50M | -40.30M | |||||||||||||||||||||||
| Change in Capital Stock | |||||||||||||||||||||||||
| Common Stock IssuedStock Issued | 25.03M | 3.37M | 3.33M | 2.55M | 4.07M | 2.62M | 15.21M | 29.19M | 141.75M | 10.13M | 135.92M | 28.15M | 46.53M | ||||||||||||
| Net Shares Issued and RepurchasedNet Shares Issued | 25.03M | 3.37M | 3.33M | 2.55M | 4.07M | 2.62M | 15.21M | 29.19M | 141.75M | 10.13M | 135.92M | 28.15M | 46.53M | ||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 25.03M | 3.37M | 3.33M | 2.55M | 4.07M | 2.62M | 15.21M | 29.19M | 141.75M | 10.13M | 135.92M | 28.15M | 46.53M | ||||||||||||
| Other financing activities (as filed) | -0.07M | -0.11M | -0.21M | -0.05M | -0.04M | -2.92M | 2.68M | ||||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | 26.99M | 1.11M | 0.05M | 0.25M | 3.56M | 2.55M | 3.81M | 2.62M | 15.21M | 29.19M | 141.64M | -0.17M | -0.27M | -0.13M | 14.62M | 54.63M | 0.03M | 143.75M | -0.17M | 46.53M | |||||
| Additional items | |||||||||||||||||||||||||
| Exchange Rate EffectFX Effect | 0.00M | -0.02M | -0.13M | -0.12M | 0.15M | 0.07M | 0.02M | -0.03M | 0.08M | -0.20M | 0.04M | -0.10M | 0.05M | -0.66M | -0.04M | -0.09M | -0.05M | -0.04M | -0.09M | -0.04M | |||||
| Change in Cash | 15.97M | -9.20M | -7.72M | -8.77M | -9.75M | -5.54M | -4.35M | -5.42M | 6.46M | 15.34M | 126.15M | -20.23M | -19.64M | -18.94M | -0.88M | 24.77M | -34.89M | 111.42M | -37.87M | 9.11M | |||||
| Ending Cash Balance | 58.95M | 49.89M | 42.97M | 32.96M | 21.89M | 16.61M | 12.30M | 7.06M | 13.43M | 29.48M | 154.40M | 133.90M | 114.32M | 94.72M | 94.36M | 118.69M | 83.75M | 195.13M | 157.26M | 166.37M | |||||
| Free Cash FlowFCF | -10.94M | -10.15M | -7.83M | -8.63M | -11.26M | -7.94M | -8.23M | -7.96M | -8.55M | -19.00M | -15.75M | -19.89M | -19.11M | -18.38M | -13.96M | -29.32M | -34.05M | -31.56M | -36.97M | -36.75M | |||||
| Net Cash FlowNCF | 15.97M | -9.19M | -7.72M | -8.65M | -9.75M | -5.54M | -4.37M | -5.39M | 6.46M | 15.54M | 126.11M | -20.23M | -19.64M | -18.94M | -0.85M | 24.86M | -34.89M | 111.42M | -37.78M | 9.14M |
Pull Helus Pharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=HELP&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "HELP", "statement": "CF", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=HELP&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();